Innovative indkøb i sundheds- og plejesektoren kan bruges som redskab til at skabe værdifulde og bæredygtige velfærdsløsninger.
Disse præsentationer giver et bud på, hvordan dette kan gøres i praksis og tager på forskellig vis fat på værdien i dialog.
Præsentationerne blev vist d.20.november 2014 i forbindelse med en nordisk konference støttet af Nordic Innovation.
An Introduction to Eurostars - an Opportunity for SMEs to Collaborate Interna...KTN
This webinar highlighted opportunities within the EUREKA Eurostars programme and how Innovate UK KTN and partners can help your business to innovate and go international.
While open innovation is a defined concept, its methodology differs based on what companies are using it. Two cases - Inwido and Tetra Pak - take an open innovation approach to solving their internal challenges. Having chosen different approach to implement open innovation practices, both projects arrive to successful outcomes. Success factors for open innovation include involvement of top management, setting clear strategy for openness and participation and creation of open ecosystem. his presentation was held at the "Hands On - Open Innovation" one day workshop arranged by Ideon Open in Lund, Sweden.
More information about the event is at http://www.ideonopen.com/events
Open Innovation - Best Practices for Raw Material CompaniesTimo Ropponen
Mining and raw materials companies have longer and costly innovation cycles.The objective of the project was to build on top of the established Open Innovation (OI) body of knowledge a set of best practices and tools specifically tailored to raw material companies. The project consisted of an open innovation assessment study and piloting a digital collaboration tool in an online OI workshop in a mining company.
Show Me The Money London 2014 - Presentation by Carolina Carolina Fernandes, ...TechMeetups
Carolina is Innovation & Funding Manager and EU R&D Advisor at Enterprise Europe Network London, a consortium led by GLE Group and powered by the European Commission (EC) to provide business support to local SMEs, from access to funding to technology transfer, with a component of innovation management.
Green Tec Cluster NRW - Services for Research & Innovation in GermanyJan Nicolai Hennemann
Clusters are regional and interregional networks in which companies, research facilities, political and non-profit institutions cooperate all along the value chain. The cluster policy of North Rhine-Westphalia's government aims to "strengthen strengths", supporting such partnerships in 16 different industries and technological fields.
The environmental technology cluster Umwelttechnologien.NRW works under the auspices of North Rhine-Westphalia's Ministry for Climate Protection, Environment, Agriculture, Nature Conservation and Consumer Protection (www.mkulnv.nrw.de). The cluster pursues the central goal of continuing to improve NRW's already prominent position in the GreenTech industry. It has set itself the following guiding objectives:
1. Improve competitiveness and create high-quality and innovative jobs
2. Sensitize the international market for environmental technologies from NRW
3.Promote integrated environmental protection as an alternative to after-care approaches
4. Build up the identity of environmental technology as an industry
5. Raise the state's profile in the industry
In this presentation some of the services and initiatives in the field of research, innovation and entrepreneurship of the green tec cluster NRW are highlighted.
MANUFACTURING INDUSTRY innovation programme - Presentation leaflet - CRP Henr...CRP Henri Tudor
Our MANUFACTURING INDUSTRY innovation programme aims to join forces with key players in the
manufacturing industry to overcome their challenges:
• development of new functional and intelligent materials
• analysis, testing and validation of materials
• consideration of environmental aspects in the design and development of innovative products,
procedures and services
• Life-Cycle Analysis and the eco-design of products, as well as energy optimisation of procedures and
processes
Let’s talk about innovation
Join the #1 Glocal community of Thinkers, Creatives and Disruptive Innovators.
An opportunity to connect and collaborate with people in similar roles, pursuing similar goals and facing similar challenges: people you wish you had more of in your company.
You’ll bring your challenges, work on solutions, and leave with clarity on what and how to implement once back in the office.
With the support of all those new friends, you met during the summit.
IGNITE your…. TSB grants
Presenter – Mark Glover, Director Business Planning, from Technology Strategy Board will be presenting on
“The support to small businesses provided by the various TSB grants and schemes"
Mark is responsible for the definition and management of organisational strategy, strategic partnerships, EU and international engagement and organisational improvement and change.
The Technology Strategy Board is the UK's innovation agency. Our goal is to accelerate economic growth by stimulating and supporting business-led innovation.
COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN
PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL
COMMITTEE AND THE COMMITTEE OF THE REGIONS
Europe 2020 Flagship Initiative
Innovation Union
Innovative indkøb i sundheds- og plejesektoren kan bruges som redskab til at skabe værdifulde og bæredygtige velfærdsløsninger.
Disse præsentationer giver et bud på, hvordan dette kan gøres i praksis og tager på forskellig vis fat på værdien i dialog.
Præsentationerne blev vist d.20.november 2014 i forbindelse med en nordisk konference støttet af Nordic Innovation.
Innovative indkøb i sundheds- og plejesektoren kan bruges som redskab til at skabe værdifulde og bæredygtige velfærdsløsninger.
Disse præsentationer giver et bud på, hvordan dette kan gøres i praksis og tager på forskellig vis fat på værdien i dialog.
Præsentationerne blev vist d.20.november 2014 i forbindelse med en nordisk konference støttet af Nordic Innovation.
More Related Content
Similar to Dialog mellem offentlige og private i praksis
An Introduction to Eurostars - an Opportunity for SMEs to Collaborate Interna...KTN
This webinar highlighted opportunities within the EUREKA Eurostars programme and how Innovate UK KTN and partners can help your business to innovate and go international.
While open innovation is a defined concept, its methodology differs based on what companies are using it. Two cases - Inwido and Tetra Pak - take an open innovation approach to solving their internal challenges. Having chosen different approach to implement open innovation practices, both projects arrive to successful outcomes. Success factors for open innovation include involvement of top management, setting clear strategy for openness and participation and creation of open ecosystem. his presentation was held at the "Hands On - Open Innovation" one day workshop arranged by Ideon Open in Lund, Sweden.
More information about the event is at http://www.ideonopen.com/events
Open Innovation - Best Practices for Raw Material CompaniesTimo Ropponen
Mining and raw materials companies have longer and costly innovation cycles.The objective of the project was to build on top of the established Open Innovation (OI) body of knowledge a set of best practices and tools specifically tailored to raw material companies. The project consisted of an open innovation assessment study and piloting a digital collaboration tool in an online OI workshop in a mining company.
Show Me The Money London 2014 - Presentation by Carolina Carolina Fernandes, ...TechMeetups
Carolina is Innovation & Funding Manager and EU R&D Advisor at Enterprise Europe Network London, a consortium led by GLE Group and powered by the European Commission (EC) to provide business support to local SMEs, from access to funding to technology transfer, with a component of innovation management.
Green Tec Cluster NRW - Services for Research & Innovation in GermanyJan Nicolai Hennemann
Clusters are regional and interregional networks in which companies, research facilities, political and non-profit institutions cooperate all along the value chain. The cluster policy of North Rhine-Westphalia's government aims to "strengthen strengths", supporting such partnerships in 16 different industries and technological fields.
The environmental technology cluster Umwelttechnologien.NRW works under the auspices of North Rhine-Westphalia's Ministry for Climate Protection, Environment, Agriculture, Nature Conservation and Consumer Protection (www.mkulnv.nrw.de). The cluster pursues the central goal of continuing to improve NRW's already prominent position in the GreenTech industry. It has set itself the following guiding objectives:
1. Improve competitiveness and create high-quality and innovative jobs
2. Sensitize the international market for environmental technologies from NRW
3.Promote integrated environmental protection as an alternative to after-care approaches
4. Build up the identity of environmental technology as an industry
5. Raise the state's profile in the industry
In this presentation some of the services and initiatives in the field of research, innovation and entrepreneurship of the green tec cluster NRW are highlighted.
MANUFACTURING INDUSTRY innovation programme - Presentation leaflet - CRP Henr...CRP Henri Tudor
Our MANUFACTURING INDUSTRY innovation programme aims to join forces with key players in the
manufacturing industry to overcome their challenges:
• development of new functional and intelligent materials
• analysis, testing and validation of materials
• consideration of environmental aspects in the design and development of innovative products,
procedures and services
• Life-Cycle Analysis and the eco-design of products, as well as energy optimisation of procedures and
processes
Let’s talk about innovation
Join the #1 Glocal community of Thinkers, Creatives and Disruptive Innovators.
An opportunity to connect and collaborate with people in similar roles, pursuing similar goals and facing similar challenges: people you wish you had more of in your company.
You’ll bring your challenges, work on solutions, and leave with clarity on what and how to implement once back in the office.
With the support of all those new friends, you met during the summit.
IGNITE your…. TSB grants
Presenter – Mark Glover, Director Business Planning, from Technology Strategy Board will be presenting on
“The support to small businesses provided by the various TSB grants and schemes"
Mark is responsible for the definition and management of organisational strategy, strategic partnerships, EU and international engagement and organisational improvement and change.
The Technology Strategy Board is the UK's innovation agency. Our goal is to accelerate economic growth by stimulating and supporting business-led innovation.
COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN
PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL
COMMITTEE AND THE COMMITTEE OF THE REGIONS
Europe 2020 Flagship Initiative
Innovation Union
Similar to Dialog mellem offentlige og private i praksis (20)
Innovative indkøb i sundheds- og plejesektoren kan bruges som redskab til at skabe værdifulde og bæredygtige velfærdsløsninger.
Disse præsentationer giver et bud på, hvordan dette kan gøres i praksis og tager på forskellig vis fat på værdien i dialog.
Præsentationerne blev vist d.20.november 2014 i forbindelse med en nordisk konference støttet af Nordic Innovation.
Innovative indkøb i sundheds- og plejesektoren kan bruges som redskab til at skabe værdifulde og bæredygtige velfærdsløsninger.
Disse præsentationer giver et bud på, hvordan dette kan gøres i praksis og tager på forskellig vis fat på værdien i dialog.
Præsentationerne blev vist d.20.november 2014 i forbindelse med en nordisk konference støttet af Nordic Innovation.
Innovative indkøb i sundheds- og plejesektoren kan bruges som redskab til at skabe værdifulde og bæredygtige velfærdsløsninger.
Disse præsentationer giver et bud på, hvordan dette kan gøres i praksis og tager på forskellig vis fat på værdien i dialog.
Præsentationerne blev vist d.20.november 2014 i forbindelse med en nordisk konference støttet af Nordic Innovation.
Innovative indkøb i sundheds- og plejesektoren kan bruges som redskab til at skabe værdifulde og bæredygtige velfærdsløsninger.
Disse præsentationer giver et bud på, hvordan dette kan gøres i praksis og tager på forskellig vis fat på værdien i dialog.
Præsentationerne blev vist d.20.november 2014 i forbindelse med en nordisk konference støttet af Nordic Innovation.
Innovative indkøb i sundheds- og plejesektoren kan bruges som redskab til at skabe værdifulde og bæredygtige velfærdsløsninger.
Disse præsentationer giver et bud på, hvordan dette kan gøres i praksis og tager på forskellig vis fat på værdien i dialog.
Præsentationerne blev vist d.20.november 2014 i forbindelse med en nordisk konference støttet af Nordic Innovation.
Innovative indkøb i sundheds- og plejesektoren kan bruges som redskab til at skabe værdifulde og bæredygtige velfærdsløsninger.
Disse præsentationer giver et bud på, hvordan dette kan gøres i praksis og tager på forskellig vis fat på værdien i dialog.
Præsentationerne blev vist d.20.november 2014 i forbindelse med en nordisk konference støttet af Nordic Innovation.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
2. Oslo Medtech
A national cluster
supporting and nourishing
the business development
of superior medical
research, stimulating the
development of a
competitive Norwegian
Medtech, eHealth and
Assistive technology
industry
3. Stimulate and facilitate for innovation and growth
• Facilitate cooperation between R&D,
companies and hospitals/local
authorities
• Stimulate and facilitate market driven
innovation projects and procurement
processes
• Facilitate clinical trials and testing
• Enhance the knowledge of
International markets and help
companies to reach the global market
• Attract development and investment
capital
5. Example – development of home market
Subcontractor
Subcontractor
Subcontractor
Subcontractor
Subcontractor
Subcontractor
6. Initiatives in Norway with focus on Public procurement
of innovative solutions.
The vision of the program
Public sector customers and suppliers with
focus on the future.
Who is behind it?
Agency for Public Management and
eGovernment (Difi) have got the
mandate to strengthen the
government's work in renewing the
Norwegian public sector
7. The combination of an
ageing population and
fewer people in work
requires new solutions
WELFARE TECHNOLOGY IN OMSORG+
Demanding customer
City of Oslo
Supplier
Hospital IT (welfare
technology) with Ascom
AS as subcontractor for
the safety alarm
Facilitator
National Programme for
Supplier
Development/Regional
Programme for Supplier
Development – Greater
Oslo
Sector mobilisation
Norsk Teknologi and
Oslo Medtech
When
2011
8. Assess needs
Market dialogue The tender process
WELFARE TECHNOLOGY IN OMSORG+
1
3
2
4
Plan and organise
• New care concept with smart home
technology
• Integrated system for connecting
multiple products
• Open dialogue conference (110
delegates)
• Supplier workshop hosted by Oslo
Medtech
• Suppliers submitted written solution
proposals (33 submissions)
• One-on-one meetings
• Worked up a performance and
functional requirements specification
for the entire Omsorg+ concept
• Based on this specification, the city
compiled a specific requirements
specification for the procurement of a
smart home platform and a basic
package of welfare technologies for
Omsorg+ Kampen.
• Executed as an open tender
• Firm commitment from management
• Interdisciplinary specialist task force
City of Oslo
9. RESULTS
• An open system that allows for continuous product
innovation
• Research collaboration with the Department of
Informatics at the University of Oslo
• New procurement strategy
WELFARE TECHNOLOGY IN OMSORG+
INNOVATIONS
• Dialogue with the market produced new and
unfamiliar ideas
• The description of the procurement became better
adapted to the city’s needs
• The requirements specification is being used for
other care homes
• New insights into needs increases supplier
competitiveness
PURCHASER
EVA HURTIG
Head of the city council’s department for
the elderly and social services in Oslo
“The dialogue has helped suppliers gain more insight
into how the city thinks and its expectations. The
City of Oslo has gained more knowledge of what
suppliers can offer and we have designed our
requirements specification as a functional description
with basic requirements and additional
requirements.”
SUPPLIER
ROGER SLETTA
Sales Manager at Hospital IT AS
“I am full of praise for the way the city worked to
get an overview of and insight into the supplier
market in this project. It is important to have
knowledge of the status of the market and what it
is in a position to deliver – especially when it
comes to innovative solutions.”
10. Guide for Public Procurement of innovative solutions
in the health sector
Accelerators for innovation:
- Clear vision of user needs / challenges
- Market dialogue before writing the tender
- Use of functional requirements in the tender specification
- To establish pre commercial procurement projects as part of overall procurement process
- Use of Competitive dialogue
- Uncover the real costs and think in terms of whole life-cycle costs
- Anchoring of innovation strategy in the organization
Solution
design
Prototype
Test and
verification
Competitive
Tender
Contract
Delivery
and
evaluation
Challenge
and Needs’
assessment
Planning
and
organizing
Dialogue
with market
Strategy and
Competition
design
No
Phase 2 - Pre-Commercial Procurement (PCP)
Phase 3 – Innovative Public Procurement (IPP)
Phase 1 - Preparation and anchoring Yes
Solution?
11. Need assessment and
Dialogue activities
Example from Oslo Municipality – procurement of
new solutions for safety alerts to disabled people
living in their homes.
12. Steps taken
29.09.13
Wish I had
seminar – “safe
and high quality of life
staying longer in my
house”
05.11.13
Internal user
workshop
(Need’s
assessment)
15.11.13
Market
dialogue and
partnering
4-6.12.13
One-to-One
meetings with
suppliers
Dec and Jan
Procurement
strategy
Starting point:
• Technological development gives new possibilities
• Existing agreement for safety alarms with suppliers ending fall 2014
• Little competition and few possible suppliers
• Oslo Municipality invited Oslo Medtech to become facilitator of process
13. Wish I had seminar- «safe and high
quality of life staying longer in my own
house»
Aker Hospital 29.08.2013
«Almas house»
90
participants
14. Increased safety
Challenges for “Wish I had seminar”
Need / Challenges:
1. Falling/dizziness
2. Confusion, time perception
3. Going out at night
4. Concern
5. Social contact
• Afraid of going out
• Not able to use modern
technology
6. Forget to eat and take
medicine
7. Is everything okay at home?
8. Improved patient care
1
2
34
5
6
78
16. Dialogue conference with industry
Time Program
08:30 Welcome
08:45 About procurement of innovative solutions
Kari Sletnes, Deputy Director health agency
09:00 Challenges and needs for solutions that can help disabled people
stay home in a safe situation and with high quality.
Bente Riis, Oslo Municipality & Odd Arild Lehne, Oslo Medtech
09:45 Presentation of companies, dialogue and feedback. Existing and
immature technology and solutions
Facilitator: Kathrine Myhre, Oslo Medtech
11:00 Lunch
11:20 Partnering and matchmaking
Facilitator: Kathrine Myhre, Oslo Medtech
13:00 End
52
participants
17. Part two: Partnering
All companies are invited to give a 2 minute presentation:
1. Who you are what company you represent
2. Short presentation of your company with regards to
products, services and solutions that are relevant to
presented need.
3. Feedback to the presented challenge.
4. In need for partners?
18. One-to-One meetings with industry
• Separate meetings - 30 minutes
• Ambition
• Invite the industry to a safe and open dialogue
• Get a better understanding of the written solution sent in
by the company
• Communication
• Open announcement on Doffin (Ted)
• Information at the procurers homepage
• Announcement in Media
• The suppliers are invited to send in written solutions the
the challenge. Those how send in solutions are invited to
a separate meeting.
• Agenda for the meeting
• Same agenda for all the meetings.
• The suppliers present their solution
• Discussion about the solution sent in
• The written information is kept confidential.
• Important: equal treatment of all suppliers!
Company at the dialogue meeting
“We are very
positive to the
involvement and
participation from
the suppliers”
Procurer: Morten Thorgersen
It is important that
Oslo Municipality
takes the risk of
trying out new
solutions
19. Important: Public Procurement as part of an
overall procurement strategy
19
Innovative solutions need to coexist with mature solutions
23. Lesson learned from process together with Oslo Municipality
• Importance of visionary leadership and involvement from
professionals
• Holistic solutions require process and strategy
• Dialogue activities provides purchasers new and updated
knowledge on available technologies and solutions, and opens
up for new ideas and solutions
• It is demanding to write the first function-based tender
specification
• Need for facilitation of the process...
Organized in the right way, the cooperation between public
service providers and the private sector, will result in better
solutions at a lower total cost of ownership.
24. Example: Utbudshjulet Indkøbsafdelingen i Region Syddanmark
Link til Region Syddanmarks
pressemeddelelser om dialog ved
udbud samt guide om gennemførelse af
høring.
http://regionsyddanmark.dk/wm408430
28. Some examples of dialogue activities
Market Research
• Survey of what exists in the market
Dialogue Conference
• Presentation and dialogue about specific challenges
One-to-one meetings
• In depth understanding of upcoming innovative solutions / possibilities
Planning and design competitions
• Invite innovative entrepreneurs and companies to develop concept notes
for innovation
29. Best Practice and key learning
points from public procurement of
innovative solutions in the Nordic
Health Sector
Solution
design
Prototype
Test and
verification
Competitive
Tender
Contract
Delivery
and
evaluation
Challenge
and Needs’
assessment
Planning
and
organizing
Dialogue
with market
Strategy and
Competition
design
No
Phase 2 - Pre-Commercial Procurement (PCP)
Phase 3 – Innovative Public Procurement (IPP)
Phase 1 - Preparation and anchoring Yes
Solution?
30. Main findings best practice and key learning point report
Phase one:
• The effect of a well-organized market dialogue is triple.
• Lack of proper integration with existing solutions and problems with aging
infrastructure in the hospitals might hinder the innovation.
• Strong anchoring of strategy in the management and involvement of user groups is
crucial.
• Tender specification based on functionality rather than detailed technical
requirements are important to promote innovative solutions.
31. Main findings best practice and key learning point report
Phase two:
• The innovation is not an integral consideration in planned procurement processes
• Small companies experience substantial challenges when dealing with big
institutions. E.g. contracts, capacity, financial strength and cultural differences.
• Idealists are in charge of the project, and tend to fail during the anchoring phase.
• Lack of risk assessment and cost/benefit calculations
• The above-mentioned issues tend to prevent further commercialization of the
projects
32. Main findings best parctice and key learning point report
Phase three
• It is about best value – not lowest price
• Use of Competitive Dialogue gives better results
• Resistance for change of procedures among procurers and lawyers hinder the
innovation.
• There is a tendency towards larger procurement units and tender volumes.
33. Building the Nordic region as a strong home market for
international export of health care solutions
Export
34. Partners in the PPI Net consortium:
Denmark: Finland: Sweden: Norway:
35. Juridical guidelines
Guide for innovative
procurement
Report best practice and
key learning points
www.nordicppi.net
Bent-Håkon Lauritzen
Advisor Innovative Procurement
Oslo Medtech
www.oslomedtech.no
bhl@oslomedtech.no
Cell: +47 91844164
Nordic PPI Net – final conference
Odense February 5th 2015